AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 616695385 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation in an academic course and a social networking and support website for 24 months
Number of subjects: 0
Study 34955173 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal Stretching with Photobiomodulation Therapy (PBMT)
Number of subjects: 103
Study 34955173 — intervention group
Group type: COMPARATOR
Intervention: Vaginal Stretching with Sham PBMT
Number of subjects: 103
Study 34955173 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal Stretching with PBMT
Number of subjects: 103
Study 34059568 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric training (PMT)
Number of subjects: 100
Study 34059568 — intervention group
Group type: COMPARATOR
Intervention: Control group (regular PE classes)
Number of subjects: 100
Study 32620210 — intervention group
Group type: EXPERIMENTAL
Intervention: GC-avelumab (gemcitabine 1000 mg/m2 on days 1 and 8, Cisplatin 70 mg/m2 on day 1, plus Avelumab 10 mg/kg every 3 weeks)
Number of subjects: 90
Study 32620210 — intervention group
Group type: COMPARATOR
Intervention: GC (gemcitabine 1000 mg/m2 on days 1 and 8, Cisplatin 70 mg/m2 on day 1)
Number of subjects: 90
Study 36137654 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical management (preferred by neurosurgeons)
Number of subjects: 60
Study 36137654 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment (preferred by interventional neuroradiologists)
Number of subjects: 60
Study 36137654 — intervention group
Group type: COMPARATOR
Intervention: Agreement among specialists
Number of subjects: 60
Study 36137654 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial participation offer
Number of subjects: 60
Study 32132141 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 2158
Study 32132141 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2158
Study 616639227 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxford House (OH) recovery homes
Number of subjects: 200
Study 616639227 — intervention group
Group type: COMPARATOR
Intervention: Usual aftercare (UA)
Number of subjects: 200
Study 35760542 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbiota mixture (two enemas of deep-frozen stored stool microbiota mixed from eight healthy donors)
Number of subjects: 99
Study 35760542 — intervention group
Group type: COMPARATOR
Intervention: Placebo (two enemas of autoclaved microbiota mixture)
Number of subjects: 99
Study 35760542 — intervention group
Group type: COMPARATOR
Intervention: Placebo (only)
Number of subjects: 99
Study 35760542 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbiota mixture
Number of subjects: 99
Study 35152197 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy with induction chemotherapy (Cisplatin 75 mg/m2 and Paclitaxel 175 mg/m2 every 21 days) followed by concurrent chemoradiotherapy (66Gy in 33 fractions for 6.5 weeks)
Number of subjects: 25
Study 35152197 — intervention group
Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy (Cisplatin 40 mg/m2 intravenous during chest radiotherapy of 66Gy in 33 fractions for 6.5 weeks)
Number of subjects: 25
Study 35152197 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy followed by concurrent chemoradiotherapy
Number of subjects: 25
Study 35152197 — intervention group
Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy alone
Number of subjects: 25
Study 32598472 — intervention group
Group type: EXPERIMENTAL
Intervention: Coban spiral application to fingers, figure of eight to hand and wrist
Number of subjects: 100
Study 32598472 — intervention group
Group type: EXPERIMENTAL
Intervention: Coban pinch application to fingers, spiral application to hand and wrist
Number of subjects: 100
Study 32598472 — intervention group
Group type: COMPARATOR
Intervention: Generic compression glove
Number of subjects: 100
Study 32598472 — intervention group
Group type: EXPERIMENTAL
Intervention: All compression methods
Number of subjects: 100
Study 35788632 — intervention group
Group type: EXPERIMENTAL
Intervention: Multispecies probiotic (specific strains corrected in the erratum)
Number of subjects: 0
Study 32881641 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma therapy, with anti-SARS-CoV-2 titers of >1:640 to >1:1000, dosage and duration not specified.
Number of subjects: 0
Study 32881641 — intervention group
Group type: COMPARATOR
Intervention: Convalescent plasma therapy, details on dosage and duration not specified.
Number of subjects: 0
Study 35576407 — intervention group
Group type: EXPERIMENTAL
Intervention: SafeCare augmented for an urban high‐risk population (SC+)
Number of subjects: 562
Study 35576407 — intervention group
Group type: COMPARATOR
Intervention: Standard home‐based mental health services (SAU)
Number of subjects: 562
Study 36326400 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency (10Hz) TMS
Number of subjects: 38
Study 36326400 — intervention group
Group type: COMPARATOR
Intervention: Sham TMS
Number of subjects: 38
Study 36326400 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment response
Number of subjects: 38
Study 36180870 — intervention group
Group type: EXPERIMENTAL
Intervention: Wobble Board Training with Cognitive Intervention (n=7)
Number of subjects: 21
Study 36180870 — intervention group
Group type: EXPERIMENTAL
Intervention: Wobble Board Training without Cognitive Intervention (n=7)
Number of subjects: 21
Study 36180870 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=7)
Number of subjects: 21
Study 34018965 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician hydroxyurea SDM toolkit (H-SDM toolkit)
Number of subjects: 120
Study 34018965 — intervention group
Group type: COMPARATOR
Intervention: Clinician pocket guide (usual care)
Number of subjects: 120
Study 34018965 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 120
Study 32915939 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin lotion 0.05%
Number of subjects: 0
Study 35638317 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine (60 mg daily for 18 weeks)
Number of subjects: 25
Study 35638317 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 32687757 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 0
Study 32687757 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo or standard treatment not specified)
Number of subjects: 0
Study 35100456 — intervention group
Group type: EXPERIMENTAL
Intervention: WaveOne Gold (WO) used in reciprocation
Number of subjects: 66
Study 35100456 — intervention group
Group type: COMPARATOR
Intervention: One Shape (OS) used in continuous rotation
Number of subjects: 66
Study 35093946 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of Rosuvastatin in addition to SSRIs therapy
Number of subjects: 20
Study 35093946 — intervention group
Group type: COMPARATOR
Intervention: Placebo in addition to SSRIs therapy
Number of subjects: 20
Study 35093946 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of Rosuvastatin
Number of subjects: 20
Study 35093946 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 34367303 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular Point Acupressure (APA)
Number of subjects: 120
Study 34367303 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound Lidocaine Cream (CLC)
Number of subjects: 120
Study 34367303 — intervention group
Group type: EXPERIMENTAL
Intervention: APA combined with CLC
Number of subjects: 120
Study 34367303 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 35833071 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 60
Study 35833071 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Control)
Number of subjects: 60
Study 36079732 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplement containing Sambucus nigra, zinc, tyndallized Lactobacillus acidophilus (HA122), arabinogalactans, vitamin D, vitamin E, and vitamin C for 30 days
Number of subjects: 0
Study 36079732 — intervention group
Group type: COMPARATOR
Intervention: Control group (young patients)
Number of subjects: 0
Study 36079732 — intervention group
Group type: COMPARATOR
Intervention: Control group (elderly patients)
Number of subjects: 0
Study 33340680 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine alcohol with 3% hydrogen peroxide (HP)
Number of subjects: 151
Study 33340680 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine alcohol (control group)
Number of subjects: 151
Study 37179984 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical total disc arthroplasty (CTDA)
Number of subjects: 98
Study 37179984 — intervention group
Group type: COMPARATOR
Intervention: Anterior cervical discectomy and fusion (ACDF)
Number of subjects: 98
Study 37179984 — intervention group
Group type: COMPARATOR
Intervention: Cervical lordosis (CL)
Number of subjects: 98
Study 37179984 — intervention group
Group type: COMPARATOR
Intervention: Cervical sagittal vertical alignment (cSVA)
Number of subjects: 98
Study 37179984 — intervention group
Group type: EXPERIMENTAL
Intervention: T1 slope
Number of subjects: 98
Study 33360382 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural Wobble Board (P-WB)
Number of subjects: 0
Study 33360382 — intervention group
Group type: COMPARATOR
Intervention: Ballistic force
Number of subjects: 0
Study 33360382 — intervention group
Group type: COMPARATOR
Intervention: Accuracy
Number of subjects: 0
Study 33360382 — intervention group
Group type: COMPARATOR
Intervention: Rest (Control group)
Number of subjects: 0
Study 33118956 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted cognitive-behavioral stress management (CBSM) course and physical activity promotion via WeChat
Number of subjects: 150
Study 33713211 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-Coated Balloon (DCB)
Number of subjects: 170
Study 33713211 — intervention group
Group type: COMPARATOR
Intervention: New-Generation Drug-Eluting Stents (DES)
Number of subjects: 170
Study 34478616 — intervention group
Group type: EXPERIMENTAL
Intervention: IAP 2015 BMI chart
Number of subjects: 1418
Study 34478616 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO 2007 BMI chart
Number of subjects: 1418
Study 32201141 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulator-enhanced training
Number of subjects: 24
Study 32201141 — intervention group
Group type: COMPARATOR
Intervention: Conventional training
Number of subjects: 24
Study 32201141 — intervention group
Group type: EXPERIMENTAL
Intervention: All students performing biopsies in a real-life situation
Number of subjects: 24
Study 35025157 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 90
Study 35792037 — intervention group
Group type: EXPERIMENTAL
Intervention: Remotely delivered exercise program for 3 months
Number of subjects: 74
Study 35792037 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 74
Study 35897500 — intervention group
Group type: EXPERIMENTAL
Intervention: BUD application (app) for food distribution
Number of subjects: 38
Study 35897500 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (not specified)
Number of subjects: 38
Study 33761570 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized homeopathic medicines (IH)
Number of subjects: 60
Study 33761570 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 36229199 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe PMNE group
Number of subjects: 43
Study 33065342 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribociclib plus fulvestrant
Number of subjects: 0
Study 33065342 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus fulvestrant
Number of subjects: 0
Study 33438346 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) with microneedling
Number of subjects: 126
Study 33438346 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) without microneedling
Number of subjects: 126
Study 33438346 — intervention group
Group type: COMPARATOR
Intervention: Control group (medical treatment only)
Number of subjects: 126
Study 32925621 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (mifepristone and misoprostol)
Number of subjects: 0
Study 32925621 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy (misoprostol alone)
Number of subjects: 0
Study 34304203 — intervention group
Group type: EXPERIMENTAL
Intervention: Early laser (group 1) at 1 week after IVR
Number of subjects: 32
Study 34304203 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferred laser (group 2) at 6 weeks or earlier after IVR
Number of subjects: 32
Study 34304203 — intervention group
Group type: EXPERIMENTAL
Intervention: Early laser (group 1)
Number of subjects: 32
Study 34304203 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferred laser (group 2)
Number of subjects: 32
Study 34922723 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-occlusion biofeedback splint
Number of subjects: 0
Study 34922723 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 32073619 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron from ASP‐p (Aspergillus oryzae grown in FePP)
Number of subjects: 35
Study 32073619 — intervention group
Group type: COMPARATOR
Intervention: Iron from FePP (ferric pyrophosphate)
Number of subjects: 35
Study 32073619 — intervention group
Group type: COMPARATOR
Intervention: Iron from FeSO4 (ferrous sulfate)
Number of subjects: 35
Study 32073619 — intervention group
Group type: EXPERIMENTAL
Intervention: ASP‐p iron absorption
Number of subjects: 35
Study 32089025 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling based on Gamble’s approach (3 sessions before delivery and 1 postpartum)
Number of subjects: 60
Study 32089025 — intervention group
Group type: COMPARATOR
Intervention: Routine prenatal care (control group)
Number of subjects: 60
Study 34135049 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium electroporation
Number of subjects: 30
Study 33613521 — intervention group
Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (NAC) as adjunct therapy during the first two months of anti-TB treatment
Number of subjects: 0
Study 33613521 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 35560474 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute heat exposure (passive heat stress using a water-perfused suit to increase body core temperature by 1.2 °C)
Number of subjects: 6
Study 35560474 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary hypoxic apneas (performed in duplicate before acute heat exposure and in recovery)
Number of subjects: 6
Study 33890858 — intervention group
Group type: EXPERIMENTAL
Intervention: Big White Wall (BWW)
Number of subjects: 790
Study 33890858 — intervention group
Group type: COMPARATOR
Intervention: Moodzone (MZ)
Number of subjects: 790
Study 34895479 — intervention group
Group type: EXPERIMENTAL
Intervention: COPP (n=444)
Number of subjects: 1287
Study 34895479 — intervention group
Group type: EXPERIMENTAL
Intervention: COPDAC (n=448)
Number of subjects: 1287
Study 34895479 — intervention group
Group type: COMPARATOR
Intervention: COPDAC
Number of subjects: 1287
Study 34895479 — intervention group
Group type: EXPERIMENTAL
Intervention: OEPA
Number of subjects: 1287
Study 34895479 — intervention group
Group type: EXPERIMENTAL
Intervention: COPP
Number of subjects: 1287
Study 34380637 — intervention group
Group type: EXPERIMENTAL
Intervention: Neratinib + Capecitabine (N+C)
Number of subjects: 621
Study 32919064 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental concussion symptom knowledge measured using 25 questions (score range 0-50)
Number of subjects: 1224
Study 32919064 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental care-seeking attitudes measured using five 7-point scale items (score range 5-35)
Number of subjects: 1224
Study 32919064 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher parental age (10-year increase)
Number of subjects: 1224
Study 32919064 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher competitiveness (10%-scale increase)
Number of subjects: 1224
Study 32919064 — intervention group
Group type: EXPERIMENTAL
Intervention: White/non-Hispanics vs. other racial or ethnic groups
Number of subjects: 1224
Study 35329107 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic (Gasteel Plus®) administered for 30 days
Number of subjects: 27
Study 35329107 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered for 30 days
Number of subjects: 27
Study 32107700 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based organized football program
Number of subjects: 40
Study 32107700 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 40
Study 34459959 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 IU/day vitamin D for 6 months
Number of subjects: 100
Study 34459959 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 33038950 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate intravenous bolus of 10% dextrose at 5 mL/kg followed by a 24-h maintenance infusion of 10% dextrose at 100 mL/kg for the first 10 kg of bodyweight, 50 mL/kg for the next 10 kg, and 20 mL/kg for each subsequent kg of bodyweight.
Number of subjects: 322
Study 33038950 — intervention group
Group type: COMPARATOR
Intervention: Observation for a minimum of 60 min and standard care.
Number of subjects: 322
Study 35440459 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT-based guided self-help intervention
Number of subjects: 60
Study 35440459 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 60
Study 34519670 — intervention group
Group type: EXPERIMENTAL
Intervention: MyT1DHero app intervention
Number of subjects: 30
Study 34044151 — intervention group
Group type: EXPERIMENTAL
Intervention: CDCM (mouthwash with β‐cyclodextrin and citrox)
Number of subjects: 176
Study 34044151 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study 36155131 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma exchange
Number of subjects: 704
Study 36155131 — intervention group
Group type: COMPARATOR
Intervention: No plasma exchange
Number of subjects: 704
Study 36155131 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced-dose glucocorticoid regimen
Number of subjects: 704
Study 36155131 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose glucocorticoid regimen
Number of subjects: 704
Study 33865473 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 34415992 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week low-calorie diet (LCD) at 800 kcal/day
Number of subjects: 556
Study 34415992 — intervention group
Group type: EXPERIMENTAL
Intervention: Throughout all phases of the DI
Number of subjects: 556
Study 34160401 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered acupressure
Number of subjects: 154
Study 34160401 — intervention group
Group type: COMPARATOR
Intervention: Sham acupoint
Number of subjects: 154
Study 34357513 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-Ebola web server with machine learning models
Number of subjects: 305
Study 32062173 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose TxA (30 mg/kg bolus, 16 mg/kg/h maintenance, 2 mg/kg pump prime)
Number of subjects: 3008
Study 32062173 — intervention group
Group type: COMPARATOR
Intervention: Low-dose TxA (10 mg/kg bolus, 2 mg/kg/h maintenance, 1 mg/kg pump prime)
Number of subjects: 3008
Study 32062173 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose TxA
Number of subjects: 3008
Study 32062173 — intervention group
Group type: COMPARATOR
Intervention: Low-dose TxA
Number of subjects: 3008
Study 34320899 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated Skill Acquisition Program (ASAP) for 2 hours
Number of subjects: 18
Study 34320899 — intervention group
Group type: COMPARATOR
Intervention: Usual and customary care (Control)
Number of subjects: 18
Study 33332190 — intervention group
Group type: EXPERIMENTAL
Intervention: Gefitinib
Number of subjects: 222
Study 33332190 — intervention group
Group type: COMPARATOR
Intervention: Vinorelbine plus Cisplatin (VP)
Number of subjects: 222
Study 33332190 — intervention group
Group type: EXPERIMENTAL
Intervention: Subsequent therapy (both groups)
Number of subjects: 222
Study 33332190 — intervention group
Group type: EXPERIMENTAL
Intervention: Subsequent targeted therapy
Number of subjects: 222
Study 33479925 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication about interval hypoglycemia
Number of subjects: 33
Study 33479925 — intervention group
Group type: EXPERIMENTAL
Intervention: Reporting of hypoglycemic events
Number of subjects: 33
Study 33479925 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoglycemia anticipatory guidance
Number of subjects: 33
Study 33479925 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling on hypoglycemia treatment or avoidance of driving
Number of subjects: 33
Study 33479925 — intervention group
Group type: EXPERIMENTAL
Intervention: Discussions of hypoglycemia unawareness
Number of subjects: 33
Study 33479925 — intervention group
Group type: EXPERIMENTAL
Intervention: Documentation in visit notes
Number of subjects: 33
Study 33059756 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin-albendazole
Number of subjects: 320
Study 33059756 — intervention group
Group type: COMPARATOR
Intervention: Kato-Katz
Number of subjects: 320
Study 36137638 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIg) and prednisolone
Number of subjects: 74
Study 36137638 — intervention group
Group type: COMPARATOR
Intervention: Intravenous human albumin (5%) and placebo tablets
Number of subjects: 74
Study 36469739 — intervention group
Group type: EXPERIMENTAL
Intervention: Detergent and water
Number of subjects: 88
Study 36469739 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial skin wipes
Number of subjects: 88
Study 36469739 — intervention group
Group type: COMPARATOR
Intervention: Control group (no decontamination)
Number of subjects: 88
Study 33445809 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumption of trans fatty acids (TFAs)
Number of subjects: 1248
Study 33445809 — intervention group
Group type: EXPERIMENTAL
Intervention: Sources of TFAs in the diet
Number of subjects: 1248
Study 32005604 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group received a head turban, sleeping socks, a heated blanket, a Bair Hugger for forced-air warming, and a Mega Acer kit for warming intravenous fluid.
Number of subjects: 54